Financing - November 12, 2021
Asgard Therapeutics raises 6 million EUR
The seed financing was co-led by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden. The funds will be used to further develop off-the-shelf and personalized therapy programs for multiple oncology indications, states the company in a press release. “The support we have received from such a strong syndicate of life science investors, is a strong […]
Financing - November 11, 2021
Sigrid Therapeutics raises 8.4 million USD
This financing round was raised from US, Irish and Swedish investors. Several family offices, among them Hans and Barbara Bergström, and the Mattsson family, founder of spice giant Santa Maria have chosen to take part in Sigrid’s recent capital raise. They are joined by investment company Crosslight Partners and, among international players, Irish investment network […]
Financing - November 8, 2021
Multimillion SEK investment in Vakona
Business angels and venture capital companies Stoaf III SciTech, Phase2Phase Biopharma and Partnerinvest Norr are backing Vakona with investments totaling SEK 15 million. “We are absolutely delighted and proud to have attracted this investment. It’s a reward for many years of hard work and takes us one step closer to clinical human trials,” says Gabriella Persson, […]
Biotech Business - November 7, 2021
US-Swedish entrepreneur invests in Intrance Medical Systems
The US-Scandinavian real estate entrepreneur Rutger Arnhult has, via his private company M2 Asset Management AB, agreed to invest in New York based Intrance Medical Systems Inc. “Investing in the life science segment is not new to me. The product has been validated by regulatory agencies in EU and a strategic buyer of the EU […]
Biotech Business - October 27, 2021
ApoGlyx closes 6 million SEK financing round
ApoGlyx has just closed a 6 million SEK investment round, coming from Almi Invest as well as from Swedish and Danish private investors. This new capital will allow the company to progress its most advanced molecule to mandatory preclinical toxicology testing. Furthermore, ApoGlyx has recently been accepted to Smile Incubator at Medicon Village in Lund. […]
Collaboration - October 20, 2021
BioLamina with partners receive funding of 40 million SEK
BioLamina with partners in the innovation milieu IndiCell receive funding to establish and propel individualized cell therapy treatments in Sweden. The funded project focuses on an autologous therapy model, in which skin cells are harvested from the patients themselves, then carefully reprogrammed into induced pluripotent stem (iPS) cells in the laboratory, and finally returned to […]
